stella
beta
A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma — Stella
Recruiting
Back to Peripheral T-cell Lymphoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Beijing Cancer Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov